Disodium clodronate tetrahydrate
Disodium clodronate tetrahydrate Basic information
- Product Name:
- Disodium clodronate tetrahydrate
- Synonyms:
-
- DICHLOROMETHYLENE-BISPHOSPHONATE, DISODIUM TETRAHYDRATE
- CLASTEON
- CLASTOBAN
- CLODRONIC ACID, DISODIUM SALT, TETRAHYDRATE
- CLODRONATE DISODIUM SALT
- CLODRONATE, DISODIUM SALT, TETRAHYDRATE
- CLODRONATE, DISODIUM, TETRAHYDRATE
- BONEFOS
- CAS:
- 88416-50-6
- MF:
- CH7Cl2NaO7P2
- MW:
- 286.9
- Mol File:
- 88416-50-6.mol
Disodium clodronate tetrahydrate Chemical Properties
- storage temp.
- 2-8°C
- solubility
- Soluble in Water (up to at least 10 mg/ml)
- form
- White solid
- color
- White
- Merck
- 14,2371
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20°C for up to 3 months.
- InChIKey
- XWHPUCFOTRBMGS-UHFFFAOYSA-L
Disodium clodronate tetrahydrate Usage And Synthesis
Description
Bisphosphonates bind strongly to bone and reduce bone resorption through effects on both osteoclasts and osteoblasts. Clodronate is a non-nitrogenous bisphosphonate that has been used in the treatment of osteoporosis and other metabolic bone diseases. It binds to hydroxyapatite crystals with an affinity constant of 0.72 μM, inhibiting their growth (IC50 = 1.34 μM) and bone resorption. Clondronate is metabolized intracellularly to a β-γ-methylene analog of ATP that is cytotoxic to both osteoclasts and macrophages, which belong to the same cell lineage as osteoclasts. Liposome-encapsulated bisphosphonates such as clodronate have been used in biological research to selectively deplete macrophage-like cells and cancer cells.
Uses
Disodium Clodronate Tetrahydrate is a bisphosphonate bone growth regulator.
Definition
ChEBI: The tetrahydrate of the disodium salt of clodronic acid. It inhibits bone resorption and soft tissue calcification, and is used as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions nd bone pain associated with skeletal metastases.
References
1) Plosker and Goa (1994), Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease; Drugs 47 945 2) Lehenkari et al. (2002), Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite; Mol.Pharmacol. 61 1255
Disodium clodronate tetrahydrateSupplier
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 021-67121386
- Sales-CN@TCIchemicals.com
- Tel
- 010-89508211 18501085097
- sales.bj@hwrkchemical.com
- Tel
- 4009903999 13355009207
- 3007715519@qq.com
Disodium clodronate tetrahydrate(88416-50-6)Related Product Information
- Pamidronate disodium salt
- CLODRONIC ACID
- Dichloromethylphenylsilane
- Etidronate disodium
- Sodium Phosphate, Dibasic
- Folic acid
- Ethyl 2-(Chlorosulfonyl)acetate
- Disodium pamidronate
- Dichlorodimethylsilane
- Ethylenediaminetetraacetic acid disodium salt
- Glycine
- 2-Chloro-5-chloromethylpyridine
- Clodronate disodium
- Sodium Monofluorophosphate
- METHYLENEDIPHOSPHONIC ACID
- CLODRONATE
- Disodium clodronate tetrahydrate
- phosphoric acid